291 related articles for article (PubMed ID: 23391444)
1. Improved intratumoral nanoparticle extravasation and penetration by mild hyperthermia.
Li L; ten Hagen TL; Bolkestein M; Gasselhuber A; Yatvin J; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
J Control Release; 2013 Apr; 167(2):130-7. PubMed ID: 23391444
[TBL] [Abstract][Full Text] [Related]
2. Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size.
Kong G; Braun RD; Dewhirst MW
Cancer Res; 2000 Aug; 60(16):4440-5. PubMed ID: 10969790
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature.
Kong G; Braun RD; Dewhirst MW
Cancer Res; 2001 Apr; 61(7):3027-32. PubMed ID: 11306483
[TBL] [Abstract][Full Text] [Related]
4. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.
Li L; ten Hagen TL; Hossann M; Süss R; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
J Control Release; 2013 Jun; 168(2):142-50. PubMed ID: 23524188
[TBL] [Abstract][Full Text] [Related]
5. Improved tumor targeting by mild hyperthermia.
Park K
J Control Release; 2013 Apr; 167(2):220. PubMed ID: 23534993
[No Abstract] [Full Text] [Related]
6. Study of non-uniform nanoparticle liposome extravasation in tumour.
Liu P; Zhang A; Xu Y; Xu LX
Int J Hyperthermia; 2005 May; 21(3):259-70. PubMed ID: 16019852
[TBL] [Abstract][Full Text] [Related]
7. A novel two-step mild hyperthermia for advanced liposomal chemotherapy.
Li L; ten Hagen TL; Haeri A; Soullié T; Scholten C; Seynhaeve AL; Eggermont AM; Koning GA
J Control Release; 2014 Jan; 174():202-8. PubMed ID: 24269966
[TBL] [Abstract][Full Text] [Related]
8. Formulation and optimization of idarubicin thermosensitive liposomes provides ultrafast triggered release at mild hyperthermia and improves tumor response.
Lu T; Lokerse WJM; Seynhaeve ALB; Koning GA; Ten Hagen TLM
J Control Release; 2015 Dec; 220(Pt A):425-437. PubMed ID: 26541464
[TBL] [Abstract][Full Text] [Related]
9. Investigation of Particle Accumulation, Chemosensitivity and Thermosensitivity for Effective Solid Tumor Therapy Using Thermosensitive Liposomes and Hyperthermia.
Lokerse WJ; Bolkestein M; Ten Hagen TL; de Jong M; Eggermont AM; Grüll H; Koning GA
Theranostics; 2016; 6(10):1717-31. PubMed ID: 27446503
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics & tissue distribution of temperature-sensitive liposomal doxorubicin in tumor-bearing mice triggered with mild hyperthermia.
Al-Jamal WT; Al-Ahmady ZS; Kostarelos K
Biomaterials; 2012 Jun; 33(18):4608-17. PubMed ID: 22459195
[TBL] [Abstract][Full Text] [Related]
11. Hyperthermia-mediated targeted delivery of thermosensitive liposome-encapsulated melphalan in murine tumors.
Chelvi TP; Jain SK; Ralhan R
Oncol Res; 1995; 7(7-8):393-8. PubMed ID: 8747602
[TBL] [Abstract][Full Text] [Related]
12. A tracer dose of technetium-99m-labeled liposomes can estimate the effect of hyperthermia on intratumoral doxil extravasation.
Kleiter MM; Yu D; Mohammadian LA; Niehaus N; Spasojevic I; Sanders L; Viglianti BL; Yarmolenko PS; Hauck M; Petry NA; Wong TZ; Dewhirst MW; Thrall DE
Clin Cancer Res; 2006 Nov; 12(22):6800-7. PubMed ID: 17121901
[TBL] [Abstract][Full Text] [Related]
13. MR characterization of mild hyperthermia-induced gadodiamide release from thermosensitive liposomes in solid tumors.
Peller M; Schwerdt A; Hossann M; Reinl HM; Wang T; Sourbron S; Ogris M; Lindner LH
Invest Radiol; 2008 Dec; 43(12):877-92. PubMed ID: 19002060
[TBL] [Abstract][Full Text] [Related]
14. Study on tumor microvasculature damage induced by alternate cooling and heating.
Shen Y; Liu P; Zhang A; Xu LX
Ann Biomed Eng; 2008 Aug; 36(8):1409-19. PubMed ID: 18470620
[TBL] [Abstract][Full Text] [Related]
15. Thermal cycling enhances the accumulation of a temperature-sensitive biopolymer in solid tumors.
Dreher MR; Liu W; Michelich CR; Dewhirst MW; Chilkoti A
Cancer Res; 2007 May; 67(9):4418-24. PubMed ID: 17483356
[TBL] [Abstract][Full Text] [Related]
16. Development of a liposomal delivery system for temperature-triggered release of a tumor targeting agent, Ln(III)-DOTA-phenylboronate.
Djanashvili K; ten Hagen TL; Blangé R; Schipper D; Peters JA; Koning GA
Bioorg Med Chem; 2011 Feb; 19(3):1123-30. PubMed ID: 20624680
[TBL] [Abstract][Full Text] [Related]
17. Tumor-type-dependent vascular permeability constitutes a potential impediment to the therapeutic efficacy of liposomal oxaliplatin.
Abu Lila AS; Matsumoto H; Doi Y; Nakamura H; Ishida T; Kiwada H
Eur J Pharm Biopharm; 2012 Aug; 81(3):524-31. PubMed ID: 22554766
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
[TBL] [Abstract][Full Text] [Related]
19. Real-time fluorescence imaging for visualization and drug uptake prediction during drug delivery by thermosensitive liposomes.
Motamarry A; Negussie AH; Rossmann C; Small J; Wolfe AM; Wood BJ; Haemmerich D
Int J Hyperthermia; 2019; 36(1):817-826. PubMed ID: 31451077
[No Abstract] [Full Text] [Related]
20. Real time 3D detection of nanoparticle liposomes extravasation using laser confocal microscopy.
Liu P; Zhang A; Zhou M; Xu Y; Xu LX
Conf Proc IEEE Eng Med Biol Soc; 2004; 2004():2662-5. PubMed ID: 17270823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]